dm+d
Unassigned
New Medicines
Newly diagnosed glioblastoma - combination therapy
Information
New molecular entity
Celgene
Celgene
Development and Regulatory status
Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials
Category
Proteasome inhibitor
In England and Wales, about 1,860 gliomas are diagnosed each year, of which 740 to 840 are glioblastoma multiform (grade 4 glioma). Median survival is 11 mtgs [2].
Newly diagnosed glioblastoma - combination therapy
Intravenous